Association of 24-hour activity patterns with risk of Alzheimer's disease, Parkinson's disease, and cognitive decline
Winer, J. R.; Lok, R.; Weed, L.; He, Z.; Poston, K. L.; Mormino, E. C.; Zeitzer, J. M.
Show abstract
Sleep-wake regulating circuits are affected during prodromal stages in the pathological progression of both Alzheimers disease (AD) and Parkinsons disease (PD). Assessment of 24-hour rhythm impairment may serve as an early indicator of disease and cognitive decline. Our objective was to determine whether objective markers of 24-hour activity are associated with subsequent development of AD, PD, and cognitive decline. This longitudinal study obtained UK Biobank data from 82,829 individuals with valid accelerometer data (collected from June 2013 to January 2016) out of 103,671 eligible adults aged 40 to 79 years with a mean ({+/-}SD) follow-up of 6.8 ({+/-}0.9) years. AD and PD diagnoses were ascertained through September 2021, with data analysis conducted March to November 2022. The outcomes were accelerometer-derived measures of 24-hour activity (derived by cosinor, nonparametric, and functional principal component methods), incident AD and PD diagnosis (obtained through hospitalization or primary care records), longitudinal tests of cognitive function, and demographic characteristics. 82,829 participants consisted of 46,683 women (56%) and 36,146 men (44%) with a mean ({+/-}SD) age of 62.0 ({+/-}7.8) years at the time of actigraphy data collection. During the follow-up period, 191 individuals converted to AD (0.2%) and 266 to PD (0.3%). After adjusting for covariates, interdaily stability, a measure of regularity, (hazard ratio [HR] per SD increase 1.24, 95% confidence interval [CI] 1.04-1.47), diurnal amplitude (HR 0.77, CI 0.64-0.93), mesor (mean activity; HR 0.73, CI 0.56-0.95), and activity during most active 10 hours (HR 0.73, CI 0.59-0.91), were each associated with an increased risk of AD. Diurnal amplitude (HR 0.28, CI 0.23-0.34), mesor (HR 0.12, CI 0.10-0.16), activity during least active 5 hours (HR 0.24, CI 0.08-0.68), and activity during most active 10 hours (HR 0.20, CI 0.16-0.25), were associated with an increased risk of PD. Several measures were additionally predictive of longitudinal cognitive test performance. In this community-based longitudinal study, objective measures of 24-hour activity were associated with elevated risk of AD, PD, and accelerated cognitive decline, suggesting actigraphy-estimated 24-hour rhythm integrity may serve as a scalable early marker of neurodegenerative disease.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Causal associations between potentially modifiable risk factors and the Alzheimer's phenome: A Mendelian randomization study 93%
- Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson’s Disease 93%
- Structural and neurophysiological alterations in Parkinson’s disease are aligned with cortical neurochemical systems 93%
Similar papers in this journal
Similar papers in this journal
- CSF Aβ38 levels are associated with Alzheimer-related decline: implications for γ-secretase modulators 92%
- Physical activity and risk of Alzheimer’s disease: a two-sample Mendelian randomization study 92%
- Susceptibility to postmortem (co)-pathologies in antemortem atrophy-based subtypes of Alzheimer’s disease 91%
Similar papers in this journal
- Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology 94%
- Plasma biomarkers of Alzheimer’s disease predict cognitive decline and could improve clinical trials in the cognitively unimpaired elderly 93%
- Deep clinical phenotyping of Alzheimer’s Disease Patients Leveraging Electronic Medical Records Data Identifies Sex-Specific Clinical Associations 93%